Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |